Woodline Partners LP Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$6.1B
Holdings
672
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (672 positions)
| Stock | Value |
|---|---|
—AUSTERLITZ ACQUISITION CORP | $7.5B |
—TREBIA ACQUISITION CORP | $7.4B |
—VPC IMPACT ACQU HOLDI III IN | $7.4B |
KROSKEROS THERAPEUTICS INC | $7.4B |
—GROWTH CAP ACQUISITION CORP | $7.4B |
—RESEARCH ALLIANCE CORP II | $7.4B |
NARIUSDINARI MED INC | $7.3B |
FRPTFRESHPET INC | $7.3B |
THCTENET HEALTHCARE CORP | $7.2B |
—MONTES ARCHIMEDES ACQUISITIO | $7.2B |
PRGOPERRIGO CO PLC | $7.2B |
ZLABZAI LAB LTD | $7.0B |
ABOSACUMEN PHARMACEUTICALS INC | $7.0B |
CLYMELIEM THERAPEUTICS INC | $7.0B |
—ATHENA TECHNOLOGY ACQUISI CO | $6.9B |
IVVDADAGIO THERAPEUTICS INC | $6.8B |
AKBAAKEBIA THERAPEUTICS INC | $6.7B |
EHCENCOMPASS HEALTH CORP | $6.6B |
CNCCENTENE CORP DEL | $6.6B |
AVIRATEA PHARMACEUTICALS INC | $6.5B |
JANXJANUX THERAPEUTICS INC | $6.5B |
—ZOGENIX INC | $6.5B |
TNGXTANGO THERAPEUTICS INC | $6.5B |
TYRATYRA BIOSCIENCES INC | $6.4B |
IPSCCENTURY THERAPEUTICS INC | $6.3B |
—ATHENE HOLDING LTD | $6.3B |
SSENTINELONE INC | $6.3B |
EWTXEDGEWISE THERAPEUTICS INC | $6.0B |
—KINNATE BIOPHARMA INC | $6.0B |
—NEXTGEN ACQUISITION CORP II | $5.9B |
—HENNESSY CAPITAL INVS CORP V | $5.9B |
IM8NINSMED INC | $5.9B |
—AGILE GROWTH CORP | $5.8B |
—ACON S2 ACQUISITION CORP | $5.8B |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $5.8B |
OLPXOLAPLEX HLDGS INC | $5.7B |
—STAMPS COM INC | $5.7B |
PRAXPRAXIS PRECISION MEDICINES I | $5.7B |
DNAYCODEX DNA INC | $5.6B |
—BIOHAVEN PHARMACTL HLDG CO L | $5.6B |
CDNSCADENCE DESIGN SYSTEM INC | $5.4B |
TSPHTUSIMPLE HLDGS INC | $5.4B |
—SCORE MEDIA & GAMING INC | $5.4B |
—REINVENT TECHNOLOGY PARTNERS | $5.3B |
XLNXEURXILINX INC | $5.3B |
CRLCHARLES RIV LABS INTL INC | $5.1B |
—BCLS ACQUISITION CORP | $5.1B |
KURAKURA ONCOLOGY INC | $5.0B |
NVSTENVISTA HOLDINGS CORPORATION | $5.0B |
BOLT1EURBOLT BIOTHERAPEUTICS INC | $5.0B |
PRVAPRIVIA HEALTH GROUP INC | $4.9B |
—REVOLUTION HEALTHCAR AQ CORP | $4.9B |
—PROMETHEUS BIOSCIENCES INC | $4.9B |
GRPHGRAPHITE BIO INC | $4.9B |
RVNCEURREVANCE THERAPEUTICS INC | $4.9B |
—ACCELERATE ACQUISITION CORP | $4.9B |
CCIXCHURCHILL CAPITAL CORP VII | $4.9B |
ELDNELEDON PHARMACEUTICALS INC | $4.8B |
RDNTRADNET INC | $4.8B |
VTRSVIATRIS INC | $4.7B |
53SBRIDGE INVT GROUP HLDGS INC | $4.7B |
—RIBBIT LEAP LTD | $4.7B |
—ATOTECH LTD | $4.7B |
—ANZU SPECIAL ACQUISITIN CORP | $4.6B |
ULCCFRONTIER GROUP HLDGS INC | $4.6B |
IOVAIOVANCE BIOTHERAPEUTICS INC | $4.6B |
SRRKSCHOLAR ROCK HLDG CORP | $4.5B |
—LEO HOLDINGS III CORP | $4.5B |
—ROTH CH ACQUISITION III CO | $4.5B |
RPIDRAPID MICRO BIOSYSTEMS INC | $4.5B |
—ENVIRONMENTAL IMPACT ACQU CO | $4.5B |
BCABBIOATLA INC | $4.4B |
—CARTESIAN GROWTH CORP | $4.4B |
—OSIRIS ACQUISITION CORP | $4.4B |
—SNAP ONE HOLDINGS CORP | $4.4B |
—PERIDOT ACQUISITION CORP II | $4.4B |
—ALKURI GLOBAL ACQUISITION CO | $4.3B |
PGYEJF ACQUISITION CORP | $4.3B |
SPRYSILVERBACK THERAPEUTICS INC | $4.2B |
COHREURCOHERENT INC | $4.2B |
—AGILITI INC | $4.2B |
CUECUE BIOPHARMA INC | $4.2B |
STROSUTRO BIOPHARMA INC | $4.1B |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $4.1B |
NRIXNURIX THERAPEUTICS INC | $4.1B |
MEIPUSDMEI PHARMA INC | $4.1B |
RELYREMITLY GLOBAL INC | $4.0B |
—HEALTH SCIENCES ACQ CORP 2 | $4.0B |
CHKPCHECK POINT SOFTWARE TECH LT | $4.0B |
—THE BEAUTY HEALTH COMPANY | $4.0B |
—EUROPEAN SUSTAINABLE GROWTH | $4.0B |
HOOKGBPHOOKIPA PHARMA INC | $4.0B |
—ARYA SCIENCES ACQUISITN CORP | $4.0B |
ALTALTIMMUNE INC | $3.9B |
—DRAGONEER GROWTH OPT CORP II | $3.9B |
—AUSTERLITZ ACQUISITION CORP | $3.9B |
—HUDSON EXECUTIVE INVES III | $3.9B |
—DIGITAL TRANSFORMATN OPT COR | $3.9B |
—COLONNADE ACQUISITION CORP I | $3.8B |
—MAGENTA THERAPEUTICS INC | $3.8B |